Patents by Inventor Alexander Wolfgang Krug

Alexander Wolfgang Krug has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating APOL-1 dependent focal segmental glomerulosclerosis
    Patent number: 11801234
    Abstract: This application describes methods of inhibiting APOL1 and treating APOL1-mediated kidney diseases comprising administering Compound I and/or a pharmaceutically acceptable salt thereof. The application also describes pharmaceutical compositions comprising Compound I and/or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: March 5, 2021
    Date of Patent: October 31, 2023
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Navita Mallalieu, Ifeatu Egbuna, Brian J. Hare, Alexander Wolfgang Krug, Shu-Pei Wu
  • METHODS OF TREATING APOL-1 DEPENDENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS
    Publication number: 20210275496
    Abstract: This application describes methods of inhibiting APOL1 and treating APOL1-mediated diseases comprising administering Compound I and/or a pharmaceutically acceptable salt thereof. The application also describes pharmaceutical compositions comprising Compound I and/or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 5, 2021
    Publication date: September 9, 2021
    Inventors: Navita Mallalieu, Ifeatu Egbuna, Brian J. Hare, Alexander Wolfgang Krug, Shu-pei Wu